
Cefzet-T 1.125 Injection
Marketer
Elkos Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Cefzet-T 1.125 Injection
Cefzet-T 1.125 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be overseen by a medical professional; adherence to the prescribed schedule is crucial. Complete the entire treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include, but aren't limited to, nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects warrant immediate medical attention. Allergic reactions (e.g., rash, pruritus, edema, dyspnea) require prompt medical assistance. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing somnolence or vertigo. Adequate rest, nutrition, and hydration are recommended for optimal recovery. Monitoring may include laboratory and diagnostic testing to assess therapeutic response.
Primary Ingredients of Cefzet-T 1.125 Injection
The provided text is "undefined," offering no content to rephrase.
Uses of Cefzet-T 1.125 Injection
Infections caused by bacteria
Major Benefits of Cefzet-T 1.125 Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strongly discouraged.
Common Side effects of Cefzet-T 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefzet-T 1.125 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cefzet-T 1.125 Injection works:
Ceftriaxone and Tazobactum, combined as Cefzet-T 1.125 Injection, offer a targeted antibacterial approach. Ceftriaxone, an antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Cefzet-T 1.125 Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefzet-T 1.125 is typically deemed safe for use in pregnancy. Preclinical trials in animals have revealed minimal or absent harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administration of Cefzet-T 1.125 Injection to breastfeeding mothers requires careful consideration. Nursing should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefzet-T 1.125 Injection could lead to drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Cefzet-T 1.125 Injection use in individuals with renal impairment. Seek medical advice.
LiverCAUTION
Administering Cefzet-T 1.125 Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the Cefzet-T 1.125 Injection dosage is generally unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefzet-T 1.125 Injection :
Omitting a scheduled dose of Cefzet-T 1.125 Injection warrants immediate physician consultation.
Facts to Know About Cefzet-T 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
